Next-generation sequencing technologies for DNA methylation analyses in cancer genomics

Epigenomics

Volumn 2, Issue 2, 2010, Pages 199-207

  Boerno, Stefan T ^a   Grimm, Christina ^a   Lehrach, Hans ^a   Schweiger, Michal Ruth ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

cancer; genome wide; methylome; next generation sequencing technology

Indexed keywords

DNA;

CANCER GROWTH; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE MAPPING; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GENE;

DNA METHYLATION; EPIGENESIS, GENETIC; GENOMICS; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 77954101917     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.09.50     Document Type: Review

References (41)

1. Hattori M, Fujiyama A, Taylor TD et al.: The DNA sequence of human chromosome 21. Nature 405 (6784), 311-319 (2000).
2. Mardis ER: Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 9, 387-402 (2008).
3. Thomas RK, Baker AC, Debiasi RM et al.: High-throughput oncogene mutation profling in human cancer. Nat. Genet. 39(3), 347-351 (2007).
4. Margulies M, Egholm M, Altman WE et al.: Genome sequencing in microfabricated high-density picolitre reactors. Nature 437(7057), 376-380 (2005).
5. Bock C, Walter J, Paulsen M, Lengauer T: Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res. 36(10), E55 (2008).
6. Feinberg AP: Phenotypic plasticity and the epigenetics of human disease. Nature 447(7143), 433-440 (2007).
7. Banerjee HN, Verma M: Epigenetic mechanisms in cancer. Biomark. Med. 3(4), 397-410 (2009).
8. Beck S, Rakyan VK: The methylome: approaches for global DNA methylation profling. Trends Genet. 24(5), 231-237 (2008).
9. Pomraning KR, Smith KM, Freitag M: Genome-wide high throughput ana lysis of DNA methylation in eukaryotes. Methods 47(3), 142-150 (2009).
10. Lister R, Ecker JR: Finding the ffth base: genome-wide sequencing of cytosine methylation. Genome Res. 19(6), 959-966 (2009).
11. Lister R, Pelizzola M, Dowen RH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
12. Weber M, Davies JJ, Wittig D et al.: Chromosome-wide and promoter-specifc analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37(8), 853-862 (2005).
13. Keshet I, Schlesinger Y, Farkash S et al.: Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38(2), 149-153 (2006).
14. Cross SH, Charlton JA, Nan X, Bird AP: Purifcation of CpG islands using a methylated DNA binding column. Nat. Genet. 6(3), 236-244 (1994).
15. Rakyan VK, Down TA, Thorne NP et al.: An integrated resource for genome-wide identifcation and ana lysis of human tissue-specifc differentially methylated regions (TDMRs). Genome Res. 18(9), 1518-1529 (2008).
16. Ball MP, Li JB, Gao Y et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27(4), 361-368 (2009).
17. Weber M, Hellmann I, Stadler MB et al.: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39(4), 457-466 (2007).
18. Down TA, Rakyan VK, Turner DJ et al.: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome ana lysis. Nat. Biotechnol. 26(7), 779-785 (2008).
19. Eckhardt F, Lewin J, Cortese R et al.: DNA methylation profling of human chromosomes 6, 20 and 22. Nat. Genet. 38(12), 1378-1385 (2006).
20. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ: Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. 38(5), 540-549 (2006).
21. Serre D, Lee BH, Ting AH: MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res. 38(2), 391-399 (2009).
22. Frommer M, Mcdonald LE, Millar DS et al.: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89(5), 1827-1831 (1992).
23. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21(35), 5427-5440 (2002).
24. Ranade SS, Chung CB, Zon G, Boyd VL: Preparation of genome-wide DNA fragment libraries using bisulfte in polyacrylamide gel electrophoresis slices with formamide denaturation and quality control for massively parallel sequencing by oligonucleotide ligation and detection. Anal. Biochem. 390(2), 126-135 (2009).
25. Xi Y, Li W: BSMAP: whole genome bisulfte sequence MAPping program. BMC Bioinformatics 10, 232 (2009).
26. Cokus SJ, Feng S, Zhang X et al.: Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452(7184), 215-219 (2008).
27. Lister R, O'Malley RC, Tonti-Filippini J et al.: Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133(3), 523-536 (2008).
28. Taylor KH, Kramer RS, Davis JW et al.: Ultradeep bisulfte sequencing ana lysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 67(18), 8511-8518 (2007).
29. Korshunova Y, Maloney RK, Lakey N et al.: Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res. 18(1), 19-29 (2008).
30. Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008).
31. Brunner AL, Johnson DS, Kim SW et al.: Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res. 19(6), 1044-1056 (2009).
32. Li JB, Gao Y, Aach J et al.: Multiplex padlock targeted sequencing reveals human hypermutable CpG variations. Genome Res. 19(9), 1606-1615 (2009).
33. Lopez J, Percharde M, Coley HM, Webb A, Crook T: The context and potential of epigenetics in oncology. Br. J. Cancer 100(4), 571-577 (2009).
34. Bian YS, Yan P, Osterheld MC, Fontolliet C, Benhattar J: Promoter methylation ana lysis on microdissected paraffn-embedded tissues using bisulfte treatment and PCR-SSCP. BioTechniques 30(1), 66-72 (2001).
35. Schweiger MR, Kerick M, Timmermann B et al.: Genome-wide massively parallel sequencing of formaldehyde fxed-paraffn embedded (FFPE) tumor tissues for copy-number-and mutation-ana lysis. PLoS ONE 4(5), E5548 (2009).
36. Kerjean A, Vieillefond A, Thiounn N, Sibony M, Jeanpierre M, Jouannet P: Bisulfte genomic sequencing of microdissected cells. Nucleic Acids Res. 29(21), E106-E106 (2001).
37. Van De Vijver MJ, He YD, Van't Veer LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25), 1999-2009 (2002).
38. Dobosy JR, Roberts JL, Fu VX, Jarrard DF: The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J. Urol. 177(3), 822-831 (2007).
39. Pushkarev D, Neff NF, Quake SR: Single-molecule sequencing of an individual human genome. Nat. Biotechnol. 27(9), 847-852 (2009).
40. Lund J, Parviz BA: Scanning probe and nanopore DNA sequencing: core techniques and possibilities. Methods Mol. Biol. 578, 113-122 (2009).
41. Branton D, Deamer DW, Marziali A et al.: The potential and challenges of nanopore sequencing. Nat. Biotechnol. 26(10), 1146-1153 (2008).